480 related articles for article (PubMed ID: 30279484)
21. Deep learning unlocks label-free viability assessment of cancer spheroids in microfluidics.
Chiang CC; Anne R; Chawla P; Shaw RM; He S; Rock EC; Zhou M; Cheng J; Gong YN; Chen YC
Lab Chip; 2024 Jun; 24(12):3169-3182. PubMed ID: 38804084
[TBL] [Abstract][Full Text] [Related]
22. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
23. Multiplexed Viability Assays for High-Throughput Screening of Spheroids of Multiple Sizes.
Marimuthu M; Gervais T
Methods Mol Biol; 2023; 2644():435-447. PubMed ID: 37142939
[TBL] [Abstract][Full Text] [Related]
24. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
25. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
Calpe B; Kovacs WJ
Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
[TBL] [Abstract][Full Text] [Related]
26. Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing.
Yu L; Chen MC; Cheung KC
Lab Chip; 2010 Sep; 10(18):2424-32. PubMed ID: 20694216
[TBL] [Abstract][Full Text] [Related]
27. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
28. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
29. Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids.
Shahi Thakuri P; Tavana H
SLAS Discov; 2017 Jun; 22(5):507-515. PubMed ID: 28324660
[TBL] [Abstract][Full Text] [Related]
30. A microfluidic gradient device for drug screening with human iPSC-derived motoneurons.
Mo SJ; Lee JH; Kye HG; Lee JM; Kim EJ; Geum D; Sun W; Chung BG
Analyst; 2020 Apr; 145(8):3081-3089. PubMed ID: 32150196
[TBL] [Abstract][Full Text] [Related]
31. Long-term fluorescence hyperspectral imaging of on-chip treated co-culture tumour spheroids to follow clonal evolution.
St-Georges-Robillard A; Cahuzac M; Péant B; Fleury H; Lateef MA; Ricard A; Sauriol A; Leblond F; Mes-Masson AM; Gervais T
Integr Biol (Camb); 2019 Apr; 11(4):130-141. PubMed ID: 31172192
[TBL] [Abstract][Full Text] [Related]
32. Formation of size-controllable tumour spheroids using a microfluidic pillar array (μFPA) device.
Lim W; Hoang HH; You D; Han J; Lee JE; Kim S; Park S
Analyst; 2018 Nov; 143(23):5841-5848. PubMed ID: 30379148
[TBL] [Abstract][Full Text] [Related]
33. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
34. A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids.
Ruppen J; Cortes-Dericks L; Marconi E; Karoubi G; Schmid RA; Peng R; Marti TM; Guenat OT
Lab Chip; 2014 Mar; 14(6):1198-205. PubMed ID: 24496222
[TBL] [Abstract][Full Text] [Related]
35. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
36. Establishment of Two Dimensional (2D) and Three-Dimensional (3D) Melanoma Primary Cultures as a Tool for In Vitro Drug Resistance Studies.
Cruz Rodríguez N; Lineros J; Rodríguez CS; Martínez LM; Rodríguez JA
Methods Mol Biol; 2019; 1913():119-131. PubMed ID: 30666602
[TBL] [Abstract][Full Text] [Related]
37. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation.
Das V; Fürst T; Gurská S; Džubák P; Hajdúch M
J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477
[TBL] [Abstract][Full Text] [Related]
38. Thermo-responsive polymer aided spheroid culture in cryogel based platform for high throughput drug screening.
Sarkar J; Kumar A
Analyst; 2016 Apr; 141(8):2553-67. PubMed ID: 27027476
[TBL] [Abstract][Full Text] [Related]
39. High-throughput screening in colorectal cancer tissue-originated spheroids.
Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M
Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529
[TBL] [Abstract][Full Text] [Related]
40. Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform.
Sabhachandani P; Motwani V; Cohen N; Sarkar S; Torchilin V; Konry T
Lab Chip; 2016 Feb; 16(3):497-505. PubMed ID: 26686985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
